Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DOK3 is a protein encoded by the DOK3 gene, acting as an adaptor protein facilitating the assembly of signaling complexes. It lacks intrinsic enzymatic activity and is crucial for regulating signaling pathways in various cell types, including B cells and innate immune cells. DOK3 participates in the signaling of Toll-like receptors, C-type lectin receptors, and B cell receptors, and it modulates immune responses and bone homeostasis. DOK3 functions as a negative regulator in some contexts, such as limiting B cell receptor signaling, and it also plays roles in promoting certain cellular processes like osteoblastogenesis. It interacts with various signaling molecules, including kinases and phosphatases, to modulate downstream effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Docking protein 3 (DOK3).